Norovirus Vaccine Study Pre-screening Questionnaire |
Welcome to our Norovirus Vaccine Study Questionnaire
Apex Trials is conducting a phase 3, randomized, observer-blinded, placebo-controlled study to evaluate the safety and efficacy of mRNA-1403, a study vaccine to prevent Norovirus acute gastroenteritis in adults 18 years of age and older. Norovirus is the leading cause of acute gastroenteritis globally, marked by sudden nausea, vomiting, and diarrhea. Additional symptoms can include abdominal pain, headache, fatigue, and chills. You would receive the vaccine (mRNA-1403) or placebo while participating in the study. You will also be asked to complete an eDiary throughout the study to capture any changes to your health.
The study will involve a total of 7 visits to our clinic (located in Guelph, Ontario) and 6 remote phone calls over a 25-month period. Reasonable compensation will be provided for time and efforts participating in the study.
If you are interested in participating in this study, the following questions will help us determine if you pre-qualify. Please provide complete and honest answers to the questions to ensure this study is a good fit for you. All information collected will be kept confidential and will not be shared without your permission except as required by law. The questionnaire will take approximately 3 to 8 minutes to complete. Your answers will be recorded, but your information will only be used for the purposes of this study.
When completing the questionnaire, please do not click your browsers back button. If you wish to proceed, click the button below to begin.